Search
Home
News
Fortune 500
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Great Place to Work
Tech
AI
Innovation
Cybersecurity
Finance
Personal Finance
Real Estate
Economy
Investing
Banking
Crypto
Leadership
Success
Future of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Analytics
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Home
News
Fortune 500
Fortune 500
Fortune Sea 500
Fortune 500 Europe
Fortune Global 500
Fortune China 500
Great Place To Work
Tech
Tech
Ai
Innovation
Cybersecurity
Finance
Finance
Personal Finance
Real Estate
Economy
Banking
Investing
Crypto
Leadership
Leadership
Success
Future Of Work
Workplace Culture
C-suite
Ceo Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Rankings
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Asia
Europe
Analytics
home
home
Drugs
Drugs
Page 27 of 29
International
Takeda’s ready to shell out $2.2 billion to settle Actos drug cases
By
Laura Lorenzetti
April 1, 2015
Leadership
Where do CEOs with addictions go when they hit bottom?
By
Daniel Bukszpan
March 25, 2015
Features
Merck halts study in light of melanoma drug’s success
By
Laura Lorenzetti
March 24, 2015
Features
How Biogen scored the most successful Alzheimer’s drug so far
By
Jen Wieczner
March 21, 2015
Finance
Valeant comes out a winner after upping its Salix bid to $11.1 billion
By
Laura Lorenzetti
March 16, 2015
Features
FDA approves the first biosimilar for the U.S. market
By
Laura Lorenzetti
March 6, 2015
Finance
AbbVie to buy cancer drug maker Pharmacyclics in $21 billion deal
By
Reuters
March 5, 2015
Retail
Rite Aid takes aim at CVS with a $2 billion purchase
By
Laura Lorenzetti
February 11, 2015
Features
Biosimilars may one day save your life. But what are they?
By
Laura Lorenzetti
February 6, 2015
Finance
After Allergan loss, is Valeant dumpster diving?
By
Jen Wieczner
January 31, 2015
How to stop generic drug shortages: end hospital group purchasing kickbacks
By
Phillip L. Zweig
and
Robert A. Campbell
January 30, 2015
Report predicts 18 states will legalize pot by 2020
By
TIME
January 26, 2015
Features
Regeneron vaults ahead of Amgen in race to market cholesterol drug
By
Reuters
January 26, 2015
Retail
High stakes: How this marijuana company gained buzz in a budding market
By
Entrepreneur
and
Ben Geier
December 26, 2014
Leadership
The war on drugs comes to Corporate America
By
Chris Matthews
December 2, 2014
Most Popular
Conferences
Ray Dalio says America is developing a ‘dependency’ on the top 1% of workers, while the bottom 60% are struggling and...
By
Eleanor Pringle
Real Estate
Warren Buffett's Berkshire Hathaway and Zillow say mortgage rates can't fall enough for Americans to afford a home
By
Sydney Lake
Politics
Transportation secretary threatens to take $160 million from California over commercial driver’s licenses for...
By
The Associated Press